# Metformin as RenoProtector of Progressive Kidney Disease

> **NCT03831464** · PHASE3 · UNKNOWN · sponsor: **Universiteit Antwerpen** · enrollment: 290 (actual)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

- **DRUG:** Metformin Hydrochloride
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03831464
- **Lead sponsor:** Universiteit Antwerpen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-05
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 290 (ACTUAL)
- **Last updated:** 2023-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03831464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03831464, "Metformin as RenoProtector of Progressive Kidney Disease". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03831464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*